Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$0.23
-2.7%
$0.25
$0.19
$2.98
$7.10M1.1911.42 million shs10.38 million shs
Meren Energy Inc. stock logo
MER
Meren Energy
C$2.30
+0.4%
C$2.13
C$1.67
C$2.58
C$1.56B0.359922894,340 shs657,947 shs
10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-2.70%-2.91%-10.91%-44.10%-91.23%
Meren Energy Inc. stock logo
MER
Meren Energy
+0.44%+3.60%+11.65%+7.98%+166,666,566.67%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$0.23
-2.7%
$0.25
$0.19
$2.98
$7.10M1.1911.42 million shs10.38 million shs
Meren Energy Inc. stock logo
MER
Meren Energy
C$2.30
+0.4%
C$2.13
C$1.67
C$2.58
C$1.56B0.359922894,340 shs657,947 shs
10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-2.70%-2.91%-10.91%-44.10%-91.23%
Meren Energy Inc. stock logo
MER
Meren Energy
+0.44%+3.60%+11.65%+7.98%+166,666,566.67%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
2.50
Moderate Buy$9.003,866.51% Upside
Meren Energy Inc. stock logo
MER
Meren Energy
2.00
HoldC$2.508.70% Upside

Current Analyst Ratings Breakdown

Latest MNZS, RPS, MER, and AIM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2026
Meren Energy Inc. stock logo
MER
Meren Energy
DowngradeStrong-BuyHoldC$2.50
(Data available from 9/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
$90K76.74N/AN/A($2.99) per share-0.08
Meren Energy Inc. stock logo
MER
Meren Energy
C$727.40M2.14N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
-$13.96M-$24.68N/AN/AN/A-15,021.05%N/A-143.02%N/A
Meren Energy Inc. stock logo
MER
Meren Energy
N/A-C$0.16N/AN/AN/AN/AN/AN/AN/A

Latest MNZS, RPS, MER, and AIM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026
Meren Energy Inc. stock logo
MER
Meren Energy
N/AC$0.07N/AC$0.07N/AC$279.47 million
8/7/2026Q2 2026
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/A-$0.43N/A-$0.43N/A$0.03 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/AN/AN/AN/AN/A
Meren Energy Inc. stock logo
MER
Meren Energy
C$0.156.45%N/AN/A N/A

Latest MNZS, RPS, MER, and AIM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/20/2026
Meren Energy Inc. stock logo
MER
Meren Energy
QuarterlyC$0.046.84%8/20/20269/4/20269/4/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
N/A
2.11
2.11
Meren Energy Inc. stock logo
MER
Meren Energy
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
12.02%
Meren Energy Inc. stock logo
MER
Meren Energy
9.09%

Insider Ownership

CompanyInsider Ownership
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
0.95%
Meren Energy Inc. stock logo
MER
Meren Energy
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AIM ImmunoTech Inc. stock logo
AIM
AIM ImmunoTech
2030.44 million30.15 millionNot Optionable
Meren Energy Inc. stock logo
MER
Meren Energy
N/A676.12 millionN/AN/A

Recent News About These Companies

Meren Energy Inc MRNFF
Meren Energy (TSE:MER) Trading Up 1.8% - Should You Buy?
Ameren Missouri plans new energy center
Ameren Missouri to build 2.1GW West Alton Energy Center
Ameren to Build New Energy Plant in Missouri

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AIM ImmunoTech stock logo

AIM ImmunoTech NYSEAMERICAN:AIM

$0.23 -0.01 (-2.70%)
Closing price 09/10/2026 04:10 PM Eastern
Extended Trading
$0.21 -0.02 (-7.01%)
As of 06:57 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's lead product candidate is Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome (CFS). It is also developing Ampligen for the treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. In addition, the company provides Alferon N Injection, an injectable formulation of natural alpha interferon to treat human papilloma viruses, and genital warts, a sexually transmitted disease. AIM ImmunoTech Inc. has agreements with Amarex Clinical Research LLC; University of Cagliari Dipartimento di Scienze della Vita e dell'Ambiente; Jubilant HollisterStier; Sterling Pharma Solutions; Erasmus University Medical Center Rotterdam; Azenova, LLC; and Alcami Corporation. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.

Meren Energy stock logo

Meren Energy TSE:MER

C$2.30 +0.01 (+0.44%)
As of 09/10/2026 04:00 PM Eastern

Meren is a full-cycle Independent upstream oil and gas company with interests offshore Nigeria, Namibia, South Africa and Equatorial Guinea. Its main assets are producing and development assets in deepwater Nigeria. The Company holds a leading position in the Orange Basin including its effective interest in the Venus light oil project, offshore Namibia, and its direct interest in Block 3B/4B, offshore South Africa.